Ebola virus DNA vaccine (Vical/NIH)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameEbola virus DNA vaccine (Vical/NIH)
Drug Alias NameEbola DNA plasmid vaccineMultiple Strain Ebola DNA Plasmid VaccineVRC-EBODNA012-00-VP
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Application > Prophylactic vaccineVaccines > Biological material > Viral vaccine
Mechanisms of ActionImmunostimulants
TargetsNot applicable
Therapy Area/IndicationsHemorrhagic Fever, Ebola
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Phase 1 Clinical)
Highest Status in ChinaN/A
Originator CompaniesNational Institute Of Allergy And Infectious Diseases (Niaid)Nih Vaccine Research CenterNational Institute of Health, Islamabad
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesNih Vaccine Research CenterNational Institutes Of HealthNational Institute Of Allergy And Infectious Diseases (Niaid)
Active IndicationsN/A
Inactive IndicationsHemorrhagic Fever, Ebola

Other Information

ATC CodeN/A
Related LinksN/A